Emergent BioSolutions is looking to make progress with its chikungunya vaccine and has received a $10 million US government grant to help it along.
Emergent announced that it has been handed a research award from the Department of Defense Congressional Directed Medical Research Programs to evaluate the efficacy of its single-dose chikungunya virus vaccine candidate.
{iframe}https://endpts.com/emergent-scores-a-dod-award-to-evaluate-its-chikungunya-vaccine-in-the-field/{/iframe}